-LCB-_-LRB-
Estrogen_NN
receptor_NN
content_NN
of_IN
peripheral_JJ
blood_NN
lymphocytes_NNS
in_IN
patients_NNS
with_IN
systemic_JJ
lupus_NN
erythematosus_NN
-RCB-_-RRB-

ER_NN
content_NN
in_IN
lymphocytes_NNS
of_IN
peripheral_JJ
blood_NN
from_IN
27_CD
SLE_NN
patients_NNS
and_CC
20_CD
healthy_JJ
controls_NNS
were_VBD
determined_VBN
by_IN
dextran-coated_JJ
charcoal_NN
assay_NN
._.

ER_NN
content_NN
in_IN
lymphocytes_NNS
of_IN
each_DT
sample_NN
was_VBD
expressed_VBN
by_IN
both_CC
fmol\/mg_NN
of_IN
lymphocyte_NN
cytosolic_JJ
protein_NN
and_CC
fmol\/micrograms_NN
of_IN
lymphocyte_NN
DNA_NN
._.

The_DT
results_NNS
showed_VBD
that_IN
there_EX
was_VBD
no_DT
significant_JJ
difference_NN
between_IN
the_DT
ER_NN
content_NN
of_IN
lymphocytes_NNS
from_IN
the_DT
controls_NNS
and_CC
that_DT
from_IN
patients_NNS
with_IN
SLE_NN
._.

But_CC
the_DT
logarithmic_JJ
mean_NN
of_IN
ER_NN
content_NN
in_IN
lymphocytes_NNS
,_,
expressed_VBN
by_IN
fmol\/mg_NN
of_IN
cytosolic_JJ
protein_NN
,_,
in_IN
14_CD
patients_NNS
with_IN
active_JJ
SLE_NN
-LRB-_-LRB-
0.9356_CD
+_CC
\/_CD
-_:
0.31_CD
-RRB-_-RRB-
was_VBD
significantly_RB
higher_JJR
than_IN
that_DT
in_IN
13_CD
patients_NNS
with_IN
inactive_JJ
SLE_NN
-LRB-_-LRB-
0.2979_CD
+_CC
\/_CD
-_:
0.23_CD
,_,
P_NN
less_JJR
than_IN
0.001_CD
-RRB-_-RRB-
and_CC
in_IN
the_DT
controls_NNS
-LRB-_-LRB-
0.6204_CD
+_CC
\/_CD
-_:
0.52_CD
,_,
P_NN
less_JJR
than_IN
0.001_CD
-RRB-_-RRB-
._.

The_DT
normal_JJ
upper_JJ
limit_NN
of_IN
ER_NN
content_NN
in_IN
lymphocytes_NNS
,_,
expressed_VBN
by_IN
fmol\/micrograms_NN
of_IN
DNA_NN
,_,
was_VBD
0.136_JJ
._.

The_DT
elevated_JJ
rate_NN
of_IN
ER_NN
content_NN
in_IN
lymphocytes_NNS
in_IN
14_CD
active_JJ
SLE_NN
-LRB-_-LRB-
92.9_CD
%_NN
-RRB-_-RRB-
was_VBD
also_RB
higher_JJR
than_IN
that_DT
in_IN
quieiescent_JJ
patients_NNS
-LRB-_-LRB-
23.1_CD
%_NN
,_,
P_NN
less_JJR
than_IN
0.001_CD
-RRB-_-RRB-
and_CC
in_IN
the_DT
controls_NNS
-LRB-_-LRB-
10_CD
%_NN
,_,
P_NN
less_JJR
than_IN
0.001_CD
-RRB-_-RRB-
._.

Moreover_RB
,_,
the_DT
elevated_JJ
level_NN
of_IN
ER_NN
content_NN
was_VBD
found_VBN
to_TO
be_VB
related_JJ
to_TO
the_DT
positive_JJ
antidsDNA_JJ
antibody_NN
and_CC
hypocomplementemia_NN
._.

